Voyager Therapeutics (VYGR) Revenue (2015 - 2026)
Voyager Therapeutics (VYGR) posted Revenue of $2.6 million for Q1 2026, down 83.13% sequentially from $15.4 million in Q4 2025, and down 59.94% YoY from $6.5 million in Q1 2025.
Voyager Therapeutics (VYGR) Revenue (2015 - 2026) Analysis & Trends
Voyager Therapeutics has reported Revenue for 12 years, with the latest figure at $2.6 million in Q1 2026.
- Quarterly Revenue fell 59.94% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.5 million (down 45.46% YoY) and the FY2025 annual result came in at $40.4 million, down 49.53% from the prior year.
- Revenue retreated to $2.6 million in Q1 2026 per VYGR's latest filing, from $15.4 million in the prior quarter.
- Over five years, Revenue peaked at $150.5 million in Q1 2023 and troughed at -$1.5 million in Q4 2022.
- A 5-year average of $24.4 million and a median of $6.5 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue plunged 105.52% in 2022, then soared 22769.3% in 2023.
- Over 5 years, Revenue stood at -$1.5 million in 2022, then surged by 5913.42% to $90.1 million in 2023, then slumped by 93.01% to $6.3 million in 2024, then surged by 143.99% to $15.4 million in 2025, then sank by 83.13% to $2.6 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2.6 million, $15.4 million, and $13.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - | 3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.20 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 15.37 Mn |
| Sep 30, 2025 | 13.37 Mn |
| Jun 30, 2025 | 5.20 Mn |
| Mar 31, 2025 | 6.47 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Sep 30, 2024 | 24.63 Mn |
| Jun 30, 2024 | 29.58 Mn |
| Mar 31, 2024 | 19.50 Mn |
| Dec 31, 2023 | 90.11 Mn |
| Sep 30, 2023 | 4.61 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 150.48 Mn |
| Dec 31, 2022 | -1.55 Mn |
| Sep 30, 2022 | 41.09 Mn |
| Jun 30, 2022 | 712,000.00 |
| Mar 31, 2022 | 658,000.00 |
| Dec 31, 2021 | 28.07 Mn |
| Sep 30, 2021 | 1.48 Mn |